Blog Post | Do Postmarket Changes to Approved Medical Devices Pose Risks to Consumers?
Friday, April 27, 2018
“The authors note that despite the small safety risks that were seen during the study period, postapproval changes to Class III dermatologic devices may result in inadequately studied modifications that have the potential to influence device effectiveness and safety.”
Read Full Blog on Dermcast.tv
|
|